Clinical trial
Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to…
NCT00263003 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00263003 |
|---|---|
| Title | Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension |
| Official title | A Randomized, Open Label Comparative Study of Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Irbesartan/hydrochlorothiazide, Irbesartan |
| Enrollment | 40 |
| Start date | Jun 1, 2005 |
| First posted | Dec 7, 2005 |
| Last update posted | Dec 7, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: